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The membrane protein transhydrogenase in animal mitochondria and bacteria couples reduction of
NADP+ by NADH to proton translocation. Recent X-ray data on Thermus thermophilus transhydroge-
nase indicate a signiﬁcant difference in the orientations of the two dIII components of the enzyme
dimer (Leung et al., 2015). The character of the orientation change, and a review of information on
the kinetics and thermodynamics of transhydrogenase, indicate that dIII swivelling might assist in
the control of proton gating by the redox state of bound NADP+/NADPH during enzyme turnover.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Proton-translocating transhydrogenase is an important enzyme
found in the inner membranes of animal mitochondria and the
cytoplasmic membranes of bacteria. In the forward direction it cat-
alyzes NADP+ reduction by NADH coupled to inward proton
translocation across the membrane. Thus, the enzyme is a proton
motor in the same sense as the F1FO-ATP synthase.
Transhydrogenase in bacteria is one of several enzymes, often
operating in parallel, which supply NADPH for biosynthesis. In
Escherichia coli, for example, about one third of the NADPH needed
for biomass production can be supplied by proton-translocating
transhydrogenase [1,2]. In some bacterial species over-expression
of inserted transhydrogenase genes leads to commercially signiﬁ-
cant increases in the formation of fermentation products, such as
lysine for animal feed, by increasing the rate of NADP+ reduction [3].Transhydrogenase is strongly expressed in the mitochondria of
cells in a range of animal tissues [4]. Again, other enzymes partic-
ipate in the reduction of NADP+ in these cells and here even
approximate estimates of the contribution of transhydrogenase
to NADPH production are difﬁcult to make [5,6]. The NADPH
produced by transhydrogenase may be particularly important in
pathways responsible for the removal of damaging reactive oxygen
species (ROS) [7]. Knockdown of the transhydrogenase gene in a
human adrenocortical cell line resulted in elevated levels of ROS,
and mutations of the gene were identiﬁed in individuals with
familial glucocorticoid deﬁciency [8]. In an interesting parallel
development it was reported that mouse strains carrying deletions
in their transhydrogenase genes have impaired glucose-stimulated
insulin secretion and glucose tolerance [9,10]. It was proposed [11]
that loss of transhydrogenase in mice prevents removal of superox-
ide radicals, and hence promotes activation of the mitochondrial
uncoupling-protein 2 with consequent dissipation of the proton
electrochemical gradient and inhibition of the ATP synthesis
required for insulin secretion. Despite difﬁculties in properly
establishing genetic backgrounds [12], the transhydrogenase-
defective mouse strains may serve as useful models for under-
standing human type 2 diabetes.
Fig. 2. The four types of polypeptide organization of transhydrogenases from
representative species. Tt, Thermus thermophilus; Rr, Rhodospirillum rubrum; Ec,
Escherichia coli; Bt, Bos taurus; Eh, Entamoeba histolytica. The horizontal lines
correspond to polypeptide chains. The labels a, a1, a2 and b are names of the
polypeptide chains (but sometimes also called PntA, PntAA, PntAB and PntB,
respectively). The components dI, dII and dIII, and the hinge region, are common to
all 4 types of polypeptide organization. The small black rectangles represent
transmembrane helices (TM) numbered according to predictions on bovine
transhydrogenase but to date only visualised in X-ray structures of the T.
thermophilus enzyme [22]: question marks adjacent to the number of TM in other
species show that estimation is based only on prediction and limited biochemical
experiments.
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Transhydrogenase has three structural components (Fig. 1). The
hydrophilic components dI and dIII protrude from the membrane
on the cytoplasm side in bacteria, and dII spans the membrane.
The dI binds NADH (and product NAD+), dIII binds NADP+ (and pro-
duct NADPH), and dII conducts protons across the membrane.
Transhydrogenase has two dI–dII–dIII protomers. The joining of
the polypeptide chains within a protomer varies amongst species
(Fig. 2) but this is unlikely to signiﬁcantly inﬂuence the enzyme
mechanism. While dII is always covalently linked to dIII (through
the ‘‘hinge region’’) the dI/dII and dIII/dI components may or may
not be joined together through their polypeptide chains.
High-resolution structures of isolated dI [13–15] and dIII
[16–18], and that of a dI–dIII complex [19–21], have been pub-
lished during the last decade, and have afforded insights particu-
larly into nucleotide binding and the hydride transfer step. The
recent structure of the membrane-spanning dII at 2.8 ÅA
0
resolution,
and of the holo-enzyme at 6.9 ÅA
0
from Thermus thermophilus [22],
provide clues as to how hydride transfer from NADH to NADP+ at
the interface of dI and dIII is coupled to proton translocation
through dII. Distances are such that coupling must be mediated
by conformational changes across the protein.
Isolated dI of transhydrogenase is a stable dimer [23]. Bound
NAD+ (or NADH depending on crystallization conditions) is readily
observed in the X-ray structures of isolated dI and dI–dIII
complexes [13,14,19–21]. It occupies a classical nucleotide binding
site in one of the two Rossmann folds that comprise the dI mono-
meric unit. Interactions between the protein and the ribose group
of the nucleotide AMP moiety explain why the site strongly favors
NAD+/NADH binding over NADP+/NADPH. The nicotinamide
mononucleotide moiety of the NAD+, which carries the
redox-active nicotinamide ring, can adopt more than one confor-
mation within the binding site [24]. Two conserved polypeptide
loops of dI, the ‘‘mobile loop’’ and the ‘‘RQD loop’’ (Fig. 1), interact
with the bound nucleotide. The former, detectable in proton NMR
spectra because of its segmental mobility [25], closes down on the
surface of the protein following nucleotide binding. Mutations in
the mobile loop of Rhodospirillum rubrum dI (Rra1M226F,
Rra1T231C, Rra1G234A, Rra1Y235F, Rra1A236G, Rra1K237M – see
Fig. 2 for polypeptide nomenclature) lead to a decrease in NADH
binding afﬁnity and in the hydride-transfer rate [26]; its function
may be to exclude water from the hydride-transfer site duringFig. 1. The three-dimensional structure of transhydrogenase from T. thermophilus.
Modiﬁed from Ref. [22]. The gray bars indicate the position of the membrane. The
dashed lines delineate the short polypeptide hinges of presently unknown structure
that link dII and dIII. NAD(H) and NADP(H) correspond to nucleotides bound in the
NAD+/NADH and NADP+/NADPH sites, respectively. See text for comments on
secondary-structure features and on the orientation change of dIII.catalysis. Mutations in the RQD loop of R. rubrum dI (Rra1Q132N,
Rra1D135N, Rra1S138A) cause only small changes in NADH bind-
ing afﬁnity (Rra1R127A has a more pronounced effect) but all lead
to very strong inhibition of hydride transfer [27]. X-ray structures
of these mutant dI proteins indicate that residues in the RQD loop
are involved in positioning the dihydronicotinamide ring of NADH
for hydride transfer to NADP+ bound to dIII.
Isolated dIII proteins are monomeric and have either tightly
bound NADP+ or NADPH depending on puriﬁcation conditions.
The dIII component comprises a single, classical Rossmann fold
but the NADP+ (or NADPH) is bound in a non-classical manner with
a reverse nucleotide orientation [16,17]. Favored binding of
NADP+/NADPH relative to NAD+/NADH is ensured by interaction
between the 20 phosphate of the AMP moiety of the former and a
conserved KRS motif in loop E. The central section of this loop
arches over the pyrophosphate group of the bound nucleotide
forming a ‘‘lid’’ (Fig. 1). The protruding feature designated helix
D/loop D is conformationally mobile [28], and along with the inter-
acting loop E, is thought to have a central role in the transhydroge-
nase energy-coupling mechanism, perhaps in the crucial transition
between the open and occluded states of the enzyme (see below).
Mutations of EcbK424, EcbR425 and EcbY431 in helix E and of
EcbD392 in helix D/loop D in the intact E. coli enzyme lead to inhi-
bition of transhydrogenation activity [29–32]. Studies on these and
other mutants in loop E and helix D/loop D of isolated E. coli dIII
reveal further consequences of interactions of the protein with
NADP+ and NADPH [33,34]. In crystal structures the equivalent
residues to EcbD392 form hydrogen bonds with the pyrophosphate
and a ribose hydroxyl group of bound NADP+/NADPH [16,17]. Its
unusually high pKa, sensitive to the redox state of the bound
nucleotide [35–37], and the fact that its substitution results in a
failure in NADP+/NADPH binding [33] to isolated dIII, indicate an
important catalytic role for this residue.
Until recently information on the structure of the transmem-
brane dII component of transhydrogenase was reliant upon amino
acid sequence and biochemical analysis (see Ref. [38]. Thus, the
single-subunit enzyme from animal mitochondria was thought to
have 14 transmembrane helices (TM) per protomer, the
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from R. rubrum, 12 TM (Fig. 2). Gene fusions during evolution were
thought to increase the number of TM in the E. coli and
mitochondrial-type enzymes [39,40]. Consistent with these views,
the new X-ray structure of dII from T. thermophilus transhydroge-
nase (a three-subunit enzyme) has 12 TM per protomer, 3 in the
a2-subunit, and 9 in the b subunit [22]. The most highly conserved
of the transmembrane helices are TM2, TM3, TM4, TM9, TM10, and
especially, TM13 and TM14 (for the TM numbering system, see
Fig. 2). The proton channel through dII (one per protomer) is
thought to comprise the hexagram of TM3, TM4, TM9, TM10,
TM13 and TM14 seen in the T. thermophilus crystal structure.
Within the hexagram TM3, TM9 and TM13 form a central
three-helix bundle enclosing a ‘‘tunnel’’, perhaps the
proton-translocation pathway itself, and the bundle is surrounded
by TM4, TM10 and TM14. Six layers of amino acid residues are dis-
tinguished along the channel. Probably necessary for H+ transport,
pairs of residues in layers 3 and 4 are hydrogen bonded. There are
no ordered water molecules within the proton channel. The two
protomers of the dII dimer interact through the respective TM2.
In the holoenzyme crystal structure one dII protomer is slightly
displaced relative to the other. Conservative single-site substitu-
tions of only EcaH450 (in TM3), EcbH91 (TM9), EcbS139 (TM10),
EcbD213 (in the cytoplasmic loop between TM12 and 13),
EcbN222 (TM13), EcbG252 (TM14) and in a run of residues from
EcbK261-bR265 (in the hinge at the C-terminus of TM14 which
connects dII to dIII – see Fig. 1) of many examined in E. coli dII lead
to strong inhibition of transhydrogenase activity [30,31,41–48].
EcbH91 has often provoked interest in that it is the only conserved
protonatable residue close to the centre of the membrane dielectric
whose substitution signiﬁcantly deactivates transhydrogenation.
However, in many species (including T. thermophilus) the His is
replaced by an Asn (TtbN89); in some of these species the lost
His is accompanied by the appearance of another in TM3 (as in
TtbH42) though this is not always the case (we may speculate that
transhydrogenases in this last category do not translocate H+ but
perhaps Na+). Low concentrations of Zn++ block proton transloca-
tion through the E. coli dII channel; both FTIR [49] and X-ray
absorption studies [50] implicate a His residue in the metal-ion
binding but the role of bHis91 in the process is not yet clear. The
conserved salt bridge between TtbD202 and TtbR254 in the hinge,
which very likely has an important role in catalysis [44], is located
next to the proton channel at the membrane surface [22].
Differences in electron density of the hinge region suggest different
conformations in the two protomers. Despite extensive mutagene-
sis experiments on the dII sequence the roles of individual amino
acid residues in proton translocation and energy transduction have
remained unclear. In Fig. 3 the amino acid residue(s) responsible
for proton binding in the dII channel, and the subsequent coupling
to hydride transfer (see below), is labelled ‘‘X’’.
3. The dIII component of transhydrogenase swivels during
turnover
A most unexpected feature of the holo-enzyme X-ray structure
conﬁrmed by cross-linking inserted cysteine residues is that the
dIII component of one protomer has a ‘‘face-up’’ orientation, in
which its bound NADP+ is located close to the NAD+/NADH binding
site of dI, but the other dIII has a ‘‘face-down’’ orientation in which
the bound NADP+ would be brought into the short cytoplasmic
loops linking the TM of dII (Fig. 1) [22]. Transhydrogenase is thus
asymmetric, and its dIII components evidently swivel between
face-up and face-down orientations during turnover. Modeling
studies show that neither the holo-enzyme [22] nor dI–dIII com-
plexes [19] can simultaneously accommodate two dIII components
in the face-up orientation. The emerging view is that duringoperation transhydrogenase undergoes an alternation of sites:
the reaction sequence in one protomer runs approximately 180
out-of-phase with that in the other (Fig. 3).
Belowwe discuss the function of the dIII swivel in the context of
the transhydrogenation mechanism. In accordance with earlier
suggestions dIII in the face-up orientation is positioned for the
enzyme to catalyze hydride transfer from NADH to NADP+ but in
the light of the new holo-enzyme structure we now propose that
in its face-down orientation dIII is responsible for gating the proton
channel in dII to give H+ access to one side of the membrane or the
other.
4. The binding-change mechanism of coupling to proton
translocation in transhydrogenase
The strongest evidence on the mechanism of action of transhy-
drogenase relates to the hydride-transfer step. This takes place
with the dIII component in an ‘‘occluded state’’ in which both the
binding and release of NADP+ and NADPH are extremely slow
relative to enzyme turnover [51–53]. Crystal structures show that
with dIII in the occluded state the pro-R hydrogen atom on C4 of
the dihydronicotinamide ring of NADH (on dI) can be brought into
close apposition with the si face of C4 of the nicotinamide ring of
NADP+ (on dIII) to effect direct, stereo-speciﬁc and rapid hydride
transfer [21]. The dIII component can also adopt an ‘‘open state’’,
where NADP+ and NADPH can rapidly bind and dissociate, respec-
tively, but where hydride transfer between bound NADP+ and
NADH is blocked [36,54]. X-ray structures reveal nucleotide-
binding conformations in which the block may be achieved; essen-
tially the nicotinamide and dihydronicotinamide rings are held
apart by the enzyme [24]. The pH dependences of transhydrogena-
tion reactions in bacterial membranes suggest that protonation of
the enzyme converts open dIII into its occluded state and, subse-
quent to the hydride transfer step, deprotonation then converts
occluded dIII back into its open state [51,54,55]. Thus, the basic
mechanism is (i) substrate nucleotides, NADP+ and NADH, associ-
ate with their binding sites in an enzyme protomer having both
dIII and dI in open states, (ii) protonation of dII from the outside
aqueous phase converts the open dIII to occluded, (iii)
hydride-ion equivalents are transferred from bound NADH to
NADP+, (iv) deprotonation of dII on the cytoplasmic side regener-
ates the open state of dIII, and (v) the nucleotide products,
NADPH and NAD+, are released. The binding afﬁnities of NAD+
and NADH to dI are not signiﬁcantly altered during the catalytic
cycle; this enzyme component remains open except perhaps
during the brief (<103 s) period of hydride transfer [23,56]. The
proposed mechanism affords two important features. First, by con-
ﬁning hydride transfer to a form of the enzyme in which the
nucleotides NADP+ and NADPH remain tightly bound, it prevents
the redox step (potentially a facile reaction) from taking place
without proton translocation (‘‘slip’’). Second, it permits the
enzyme to adjust the binding properties of dIII for NADP+ and
NADPH differently in the open and occluded states: in the open
state to encourage substrate binding and product release, and in
the occluded state to favor a large equilibrium constant for hydride
transfer [57]. The consequent change in NADP+/NADPH binding
energy necessitates compensating changes in the equilibrium con-
stants of steps associated with proton binding and proton release.
5. Gating of the proton channel
To provide directionality, for example to enable the enzyme to
utilize a transmembrane proton electrochemical gradient and drive
nucleotides to an elevated ratio of [NADPH][NAD+]/[NADP+]
[NADH], the H+-translocation reaction has to be appropriately
gated: proton binding/release steps on either side of the membrane
Fig. 3. Proposed mechanism of coupling to proton translocation in transhydrogenase. Each panel diagramatically shows an intermediate in the transhydrogenase dimer as it
runs in the forward direction. One protomer of the dimer is colored red, the other blue. The relative positions of the dI, dII and dIII components correspond to those seen in the
X-ray structure of the T. thermophilus holo-enzyme (PDB, 4O9U) – see Fig. 1. The dI component is shown as a rectangle, dII as a rounded rectangle spanning the membrane,
and dIII as a trapezoid with its NADP+/NADPH binding site located at the broader end. In the face-up orientation of dIII (see text) the NADP+/NADPH binding site is located
next to the NAD+/NADH binding site of dI; in the face-down orientation the NADP+/NADPH binding site is directed into the cytoplasmic loops between the TM of dII. The dI
and dIII components and X, a proton binding site in the dII channel (see text), are shown bounded by dashed lines in open states, and solid lines in occluded states. The pairs of
parallel dashed lines in dII show allowed proton access along the channel between X and the aqueous phase on one side of the membrane or the other. The six reaction
intermediates (1–6) run approximately 180 out-of-phase in the two protomers. Thus, intermediates 1, 2, 3, 4, 5 and 6 in one protomer are paired with intermediates 4, 5, 6, 1,
2 and 3, respectively, in the other. Hydride transfer from NADH to NADP+, only possible with dIII in its occluded face-up orientation, is highlighted with a green arrow. For
simplicity, NAD+ is shown as dissociating, and NADH as binding, only to intermediate 1; in fact, NAD+ and NADH can probably reach equilibrium binding with all
intermediates on the reaction path (see text). The reverse transhydrogenation reaction, oxidation of NADPH by NAD+ coupled to H+ efﬂux, is described essentially by a simple
reversal of the reaction sequence shown in this ﬁgure.
2030 J.B. Jackson et al. / FEBS Letters 589 (2015) 2027–2033must be coordinated with the progress of the reaction [54]. In prin-
ciple, the redox state of either NAD+/NADHor NADP+/NADPH bound
to reaction intermediates could provide the trigger to allow proton
access to or from one side of the membrane or the other. However,
the dI component remains essentially in an open state during turn-
over of the enzyme (see above). Thus, NAD+ and NADH can rapidly
bind to and be released from dI throughout the transhydrogenase
reaction – they would be a poor trigger for controlling proton gat-
ing. NADP+/NADPH are amuch better proposition. In the framework
of the proposed mechanism, gating would be effectively achieved if
elements in the proton channel were to sense the redox state of
NADP+/NADPH bound to dIII, and adjust the local conformation to
allow or disallow the passage of protons to or from the solvent.
When NADP+ is bound, the channel is able to access protons only
from the outside, and when NADPH is bound, only from the cyto-
plasmic side. Thus, with NADP+ in its dIII site H+ binds into the chan-
nel from the outside (at relatively high proton electrochemical
potential in respiring bacteria) generating the occluded state and,
following reduction to NADPH, H+ is released from the channel into
the bacterial cytoplasm (at relatively low proton potential) regener-
ating the open state. A difﬁculty with this view was that previous
predictions of the holo-enzyme structure based only on X-ray data
on dI–dIII complexes had dIII in a face-up orientation [19,20]. Thus,
bound NADP+ and NADPH were thought to be held some 20 ÅA
0
or
more from the proton channel. This arrangement is essential for
direct hydride transfer from NADH (see above) but is not so well
suited for gating: the ‘‘signal’’ relaying information on the redox
state of the dIII nucleotide would have to be transmitted a consid-
erable distance to the proton channel to control the gating.
The new structure of the T. thermophilus holo-enzyme reveals
that the dIII component of one protomer is in the face-up orienta-
tion appropriate for hydride transfer; the other has a face-downorientation in which bound NADP+ or NADPH would be brought
into the short cytoplasmic loops linking the TM of dII [22]. In this
latter conformation nucleotide inﬂuence on the structure of the
proton channel is much easier to envisage. The (dihydro-) nicoti-
namide end of the bound nucleotide is proximal to the inter-TM
loops. The positive charge on the nicotinamide ring of NADP+ rela-
tive to the uncharged dihydronicotinamide ring of NADPH might
thus be sufﬁcient to switch the channel gates.
In Fig. 3 the view that dIII swivelling regulates proton gating has
been incorporated into the basic and well-supported transhydro-
genase mechanism outlined above. At the end of catalytic turnover
in a single protomer, dIII is face-down and in its open state (inter-
mediate 1, either red or blue). Release of products NAD+ and
NADPH are followed by substrate NADH and NADP+ binding.
NADP+ newly-bound to the face-down dIII (intermediate 2) trig-
gers access of the proton channel to the outside aqueous phase.
Protonation of X from the outside causes the dIII to become
occluded and swivel into the face-up orientation to enable hydride
transfer to its bound NADP+ from NADH bound to dI (intermediate
3). The still-occluded dIII, now bearing NADPH (intermediates 4
and 5), then swivels back into the face-down orientation (interme-
diate 6). The bound NADPH in its face-down dIII triggers access of
the proton channel to the inside aqueous phase where H+ is
released from X, and the dIII is converted back into the open state.
6. Alternation of sites
It is recalled that the T. thermophilus holo-enzyme structure has
one dIII in the face-up orientation and the other face-down (Fig. 1),
and that there is strong evidence that isolated dI–dIII complexes
from R. rubrum have their dIII ﬁxed in the face-up orientation,
are occluded and are capable of rapid hydride transfer between
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ation of the dimer then fall into place (Fig. 3). The two protomers
run approximately 180 out of phase: while one is completing
the hydride-transfer step with dIII in an occluded state (intermedi-
ate 3? 4), the other is preparing for the replacement of bound
product NADPH with substrate NADP+ in dIII in an open state
(intermediate 6? 1). During the period in which proton binding
from the outside aqueous phase is converting the open to the
occluded state of dIII in one protomer (intermediate 2), proton
release to the cytoplasm is converting dIII in the other from the
occluded to the open state (intermediate 6).
The available experimental evidence on transhydrogenase
would be satisﬁed if the two protomers in the ﬁgure operate inde-
pendently of one another, only occasionally and brieﬂy arrested to
prevent both dIII components simultaneously adopting the clash-
ing face-up orientation. However, this independent operation
seems unlikely since then the enzyme would function more effec-
tively as isolated protomers. It is more probable that events in the
two protomers are conformationally linked to secure a kinetic
advantage in the operation of the dimer. A conformational linkage
between the protomers is most likely at steps 2? 3 and 5? 6
where proton binding/release, interconversion of the open/oc-
cluded states, and dIII swivelling all take place. Thus, the swivelling
of face-up? face-down orientations in one protomer could be
compulsorily linked to face-down? face-up swivelling in the
other; and/or conformational changes resulting from proton bind-
ing in one protomer could be linked to conformational changes
resulting from proton release in the other. These possibilities are
not distinguished in the ﬁgure. In general, however, there are clear
indications that structural changes in one protomer are linked to
structural changes in the other – differences in the orientation of
dIII, in the structure of the dII proton channel, and in the conforma-
tions of the hinge region, of the two protomers were all referred to
above. Even in the isolated dI dimer the two NAD+/NADH binding
sites of the monomers adopt slightly different conformations, one
appropriately poised for hydride transfer, the other not [13]. It
seems likely that cooperative interactions between the two pro-
tomers of transhydrogenase are central to its mechanism of action.
It may also be noted that it has not been ruled out that the dimer
could accommodate both dIII components in the face-down orien-
tation, which might simplify our understanding of the transition,
5? 6, and that protonation/deprotonation of dIII itself is the cause
of the occluded/open transition of this component.
The development of procedures for purifying and crystallizing
the holoenzyme and its isolated components from the T. ther-
mophilus transhydrogenase opens up ways to test predictions of
the above model. Effort will be directed towards improving the
X-ray resolution of the holoenzyme. Crucially, it is predicted that
the open state of dIII will be stabilized in the face-down orientation
of this component, and this will be reﬂected in changes in the
structure of the NADP+/NADPH binding pocket. Interactions of
the (dihydro)nicotinamide group of the bound NADP+/NADPH with
amino acid residues in dII will test the prediction that the redox
state of the nucleotide is involved in gating the proton channel.
Changes in the structure of the hinge region are expected to have
a central role in the swivelling of dIII. It is anticipated that working
with low concentrations of Zn++ and the construction of mutants in
the hinge, in the dII proton channel and in the conformationally
mobile region of dIII (for example at the equivalent of EcbD392 –
see above) might be required to lock the conformational state of
the enzyme. The possibility of introducing speciﬁc mutations into
just one protomer of the dimer should help to reﬁne our under-
standing of the alternating-sites mechanism and identify points
of conformational linkage. Changes in the binding of
NADP+/NADPH are at the heart of the proposed mechanism; meth-
ods for the ﬂuorescence detection of these changes have beendeveloped for isolated dIII and should be adaptable for use in the
holoenzyme.
7. The different mechanisms of coupling to the proton
electrochemical gradient in bioenergetic machines
Although many features of the mechanism of coupling the pro-
ton electrochemical gradient to the chemical reaction catalyzed by
transhydrogenase are far from clear, it is evident that the enzyme
utilizes mechanisms unlike those of the other bioenergetic machi-
nes present in the mitochondrial inner membrane or in the bacte-
rial membrane: NADH:quinone oxidoreductase (Complex I);
quinol:cytochrome c oxidoreductase (Complex III or the bc1
Complex); cytochrome c oxidase (Complex IV); and the F1FO-ATP
synthase (Complex V). The F1FO-ATP synthase couples proton ﬂux
across the membrane through two half-channels to conformational
changes linked to rotatory motion and a threefold alternating sites
mechanism of ATP synthesis [59]. Complex I also conveys protons
across the membrane via four sets of half-channels whose open-
ing/closing conformations are gated by the chemistry occurring
at the single distant quinone binding site [60]. The chemistry of
oxygen reduction by cytochrome c oxidase is used to gate proton
channels and alter proton afﬁnities resulting in proton pumping,
but conformational changes must be subtle compared to either
Complex I or the ATP synthase [61]. Complex III has a unique
‘‘Q-cycle’’ to move charges across the membrane and a large con-
formational change of the Rieske Fe–S subunit to assure the two
electrons from quinol are bifurcated, i.e., directed to different elec-
tron acceptors [62]. The enzymology of each of these systems is
distinct from the others and each is a remarkable testament to
the different ways that evolution has solved the problem of both
generating and utilizing the proton motive force across a biological
membrane. We can now add the transhydrogenase to this list of
amazing molecular machines at the heart of bioenergetics.
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